Activity in H1 2016 | Bourse Reflex
Accueil > Actualités > Communiqués

Fermentalg (FALG) FR0011271600

€ 6.17  -0.8%
AJOUTER À : Mon Portefeuille | Ma Liste | Mes alertes

Activity in H1 2016

Jeudi 21 Jul 2016 à 20:00

Libourne – 21 July 2016 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has reported on activity during the first half of 2016.

En route towards the commercialization of DHA
The start to 2016 was marked by 2 major advances in the commercialization of DHA (Omega 3):

  • the signing of an industrial agreement for the large-scale production of DHA with ARD, a company specializing in bio-refining, industrial biotechnologies and bio-based chemistry;
  • the completion of the DHA process book which is the last stage in pre-industrialization at the company's scientific facilities in Libourne and opens the way for large-scale production.

With this in mind, Fermentalg has confirmed that it intends to launch this first product on the market between now and the end of the year.

Development milestones for the 4 other portfolio products
Alongside DHA, which is currently its most advanced product, Fermentalg has continued with the scientific and pre-industrial development work needed to launch 4 additional products between now and 2020 (DHA+, BM Bastille, Phycocyanine and Astaxanthin).

IDU construction calendar confirmed
Fermentalg also went ahead with the construction of its Industrial Development Unit (IDU) in Libourne (Gironde). So far, the building which is scheduled for delivery in the third quarter of 2016 has represented an investment of €6.2 million (out of a total estimated budget of €23 million). Commissioning, which is tied to the start of on-site production, is still planned for 2018.

€22.3 million in cash at end-June 2016
Revenues generated through partnerships amounted to €0.17 million in the first half of 2016 (compared with €0.7 million for the same period in 2015).

Thanks to its strict management, Fermentalg has the robust and healthy FINANCIAL footing needed to execute its strategic roadmap. Gross cash stood at €22.3 million on 30 June 2016.

About Fermentalg
Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Based in Libourne (Gironde), the company is looking to market 5 products between now and 2020: DHA, DHA+, BM Bastille, Phycocyanine and Astaxanthin. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at:

Press Relations:
Investor Relations:
ACTUS finance & communication
Alexandra Prisa
Tel: +33 (0)1 53 67 36 90
ACTUS finance & communication
Jérôme Fabreguettes-Leib
Tel: +33 (0)1 53 67 36 78

Partager sur Facebook
Article Précédent :
Chiffre d'affaires du premier...
Article Suivant :
CAPELLI, 1er trimestre 2016/2017 en...

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur 

Les autres actualités

Retour vers 'Communiqués' »

Mots-clés : Libourne   Specializes   Oils   Microalgae   Start   Launch   Dha+   Phycocyanine   June  
Sociétés citées dans cette news : FINANCIAL   Fermentalg   Euronext  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?